The failure of GBM to respond to anti-PD-1 is attributed to the immunosuppressive TME, which as in other “cold” tumors is characterized by a paucity of tumor infiltrating lymphocytes and a predominance of immunosuppressive myeloid cells (52–54). The gene discussed is PDCD1; the disease is glioblastoma.